Tarsus Pharmaceuticals, Inc. TARS
CIK 0001819790
Form 4 transactions dated Sep 1, 2023 to Sep 23, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $18.96K
- Sold
- $29.60M
Sep 1, 2023 – Sep 9, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale10b5-1 footnote | $942.63K 10,773 shares sold | 80.88% sold Direct holding | ▾ |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale10b5-1 footnote | $278.25K 3,180 shares sold | 66.67% sold Indirect holding | ▾ |
| 2026-09-04 | Azamian Bobak R. President/CEO and Board Chair · Director | Sale10b5-1 footnote | $905.60K 10,000 shares sold | 1.19% sold Trust holding | ▾ |
| 2026-09-04 | Neervannan Seshadri Chief Operating Officer | Sale10b5-1 footnote | $387.94K 4,564 shares sold | 5.49% sold Direct holding | ▾ |
| 2026-09-02 | Lin Elizabeth Yeu Chief Medical Officer | Sale10b5-1 footnote | $430.96K 5,387 shares sold | 28.80% sold Direct holding | ▾ |
| 2026-09-02 | Lin Elizabeth Yeu Chief Medical Officer | Sale10b5-1 footnote | $127.20K 1,590 shares sold | 25.00% sold Indirect holding | ▾ |
| 2026-09-02 | Azamian Bobak R. President/CEO and Board Chair · Director | Sale10b5-1 footnote | $800.60K 10,000 shares sold | 1.18% sold Trust holding | ▾ |
| 2026-09-01 | Lin Elizabeth Yeu Chief Medical Officer | Sale10b5-1 footnote | $339.83K 4,601 shares sold | 19.74% sold Direct holding | ▾ |
| 2026-06-17 | Azamian Bobak R. President/CEO and Board Chair · Director | Sale10b5-1 footnote | $615.49K 10,000 shares sold | 1.17% sold Trust holding | ▾ |
| 2026-06-16 | Farrow Jeffrey S See Remarks | Sale | $877.44K 14,396 shares sold | 20.22% sold Direct holding | ▾ |
Showing 30 / 37 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 37 purchase / sale groups and 30 of 79 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"TARS","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.